(Press-News.org)
A recent study published in Genes & Diseases reveals a novel role of XPR1 in promoting ovarian cancer growth by regulating autophagy and MHC-I expression. The research, conducted by scientists from Chongqing Medical University, identifies XPR1 as a critical factor influencing the aggressiveness of ovarian cancer through its interaction with LAMP1 and the PI3K/Akt/mTOR signaling pathway. These findings shed light on new therapeutic targets for ovarian cancer, a malignancy known for its poor prognosis and resistance to immune checkpoint inhibitors.
The study highlights that XPR1 expression is significantly increased in ovarian cancer tissues compared to normal ovarian tissues. This heightened expression correlates with advanced cancer stages, reduced overall survival, and lower progression-free survival. Through CRISPR-Cas9 screening, researchers identified XPR1 as a potential regulator of autophagy. Subsequent experiments confirmed that silencing XPR1 decreased ovarian cancer cell proliferation and metastasis, while overexpression led to the opposite effect, indicating its role in promoting cancer growth.
Further analysis revealed that XPR1 interacts with LAMP1, a key lysosomal-associated membrane protein, and regulates its expression. This interaction modulates autophagy flux, particularly during the early phase of autophagy and to some extent during the lysosomal phase. Silencing XPR1 led to increased lysosome formation and autophagy, while its overexpression suppressed these processes. The study demonstrated that XPR1 regulates autophagy through the PI3K/Akt/mTOR pathway, inhibiting autophagy flux and thereby promoting ovarian cancer cell survival.
In addition to autophagy regulation, the study identified a critical role of XPR1 in immune evasion. MHC-I molecules, crucial for CD8+ T cell recognition and tumor cell killing, were found to be regulated by XPR1 through autophagy. Silencing XPR1, combined with the use of chloroquine, an autophagy inhibitor, significantly enhanced the presence of MHC-I molecules on ovarian cancer cells. This combination treatment reduced tumor growth in mouse models, suggesting that targeting XPR1 alongside autophagy inhibition could improve the effectiveness of immunotherapy in ovarian cancer.
These findings suggest that XPR1 serves as a potential therapeutic target for ovarian cancer, especially in cases resistant to PD-1 and CTLA-4 inhibitors. Targeting XPR1, either through direct silencing or by using autophagy inhibitors, may offer a novel approach to enhance the immune response against ovarian cancer. The study provides a foundation for future research into the use of autophagy modulators in combination with immune checkpoint inhibitors to improve treatment outcomes.
# # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 8.4
Impact Factor: 9.4
# # # # # #
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases ).
Submissions to Genes & Disease may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx ).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.com
X (formerly Twitter): @GenesNDiseases (https://x.com/GenesNDiseases )
# # # # # #
Reference
Hui Wang, Xiaodong Luo, Bo Yang, Furong Tang, Xingwei Jiang, Hongtao Zhu, Jianguo Hu, XPR1 promotes ovarian cancer growth and regulates MHC-I through autophagy, Genes & Diseases, Volume 12, Issue 5, 2025, 101507, https://doi.org/10.1016/j.gendis.2024.101507
Funding Information:
Kuanren Talents Program and Senior Medical Talents Program of the Second Affiliated Hospital of Chongqing Medical University
Senior Medical Talents Program of Chongqing for Young and Middle-aged
Chongqing Science and Technology Bureau Project CSTB2024TIAD-KPX0038
END
CLEVELAND—Researchers at Case Western Reserve University have developed an environmentally safer type of plastic that can be used for wearable electronics, sensors and other electrical applications.
The material, a so-called ferroelectric polymer, is made without fluorine, considered a “forever” chemical that hurts the environment because compounds made with it don’t break down quickly or at all.
Although the researchers are still working to improve the material’s electric and elastic properties, the potential is vast for its flexibility of electronic uses and eco-friendly structure.
“How this material ...
Key takeaways
Researchers from Penn and Arizona State University pinpoint a lone five-particle package (a 5-plet) that could upend string theory by detecting it at the Large Hadron Collider.
“Ghost” tracks that vanish mid-flight may be the smoking gun physicists are chasing.
Early data squeeze the search window, but the next collider runs could make—or break—the case.
In physics, there are two great pillars of thought that don’t quite fit together. The Standard Model of particle physics describes all known fundamental particles and three forces: electromagnetism, ...
UNIVERSITY PARK, Pa. — Alexandra Staub, author and professor of architecture in the College of Arts and Architecture’s Stuckeman School at Penn State, examines how architects can better serve society by changing their approach to the building process in her latest book titled “Architecture and Social Sustainability: Understanding the New Paradigm.”
Published by Routledge, the book presents examples of “how we can better design for stakeholder agency, serve historically marginalized populations, and further our theoretical thinking about sustainability writ large,” according to the book’s ...
CLEVELAND—Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) grant for her research in synthetic DNA nanoparticles, which have potential applications in gene therapy.
The grant will support Mathur’s work in synthesizing nanoparticles and studying how they behave inside cells in a laboratory. She will use single-cell injections and a microscope to track the nanoparticles and watch what happens to them over time ...
Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new treatments and diagnostics easier and quicker, new research has found.
In a paper published in Nature Communications a team of researchers led from the University of Birmingham have studied blood cells from patients with a blood cancer called myelodysplastic syndrome disease (MDS). This disease often develops into a highly aggressive form of Acute Myeloid Leukaemia (AML).
Working with this new model ...
Acute hypoxemic respiratory failure (AHRF) represents one of the most common yet challenging conditions treated in intensive care units (ICUs) worldwide. While the emergence of multiple options for non-invasive respiratory support has revolutionized care in such cases, selecting the optimal approach remains difficult. Now, a special issue from the Journal of Intensive Medicine titled “Non-invasive respiratory support for acute hypoxemic respiratory failure” provides key insights to guide these critical treatment decisions.
This collection establishes a robust foundation for understanding the key respiratory support ...
LA JOLLA, CA—A new study, published recently in Nature Communications, offers the first-ever map of which parts of Chikungunya virus trigger the strongest response from the body's T cells.
With this map in hand, researchers are closer to developing Chikungunya vaccines or therapies that harness T cells to strike specific targets, or "epitopes," to halt infection. The new study also offers important clues for understanding why many people experience chronic, severe joint pain for years after clearing the virus.
"Now we can see what T cells are seeing patients with chronic disease," says LJI Assistant Professor ...
New discoveries from the Pleistocene-age Gantangqing site in southwestern China reveal a diverse collection of wooden tools dated from ~361,000 to 250,000 years ago, marking the earliest known evidence of complex wooden tool technology in East Asia. The findings reveal that the Middle Pleistocene humans who used these tools crafted the wooden implements not for hunting, but for digging and processing plants. Although early humans have worked with wood for over a million years, wooden artifacts are quite rare in the archaeological ...
Ecologists are concerned that forest ecosystems will not keep pace with a rapidly changing climate, failing to remain healthy and productive. Before the rapid climate change of the past century, tree populations in the Northern Hemisphere adapted to colder and warmer periods over thousands of years. During onsets of Ice Ages, tree populations migrated south, seeking warmer conditions as global temperatures cooled, their seeds dispersed by winds and carried by animals. When the climate warmed again, tree species adapted by migrating north to more suitable conditions. Mature trees are long-lived, and their populations can’t migrate quickly. Current climate change ...
Ecologists celebrated the release of thousands of palm-sized lake sturgeon into northwest Ohio's Maumee River in 2018, kicking off an ambitious two-decade plan to re-establish the ancient species in the waters it once called home.
More than five years later, it’s still too soon to declare success. But early signs are promising, according to recent research led by The University of Toledo and published in the peer-reviewed North American Journal of Fisheries Management.
The research tracked the first-year survival rates for cohorts released in 2018, 2019 and 2021, with results suggesting that the initiative is on track to achieve its goal of a self-sustaining ...
